Back to CAPR
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
15 competitors in Duchenne Muscular Dystrophy
View Full LandscapeDrug Information
Target Indication
Duchenne Muscular Dystrophy
Mechanism of Action
Cell Therapy
Clinical Trial
NCT05126758Last updated: 12/3/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
